Feedback / Questions
OBX-115 - Obsidian, UT MD Anderson Cancer Center
https://www.businesswire.com/news/home/20240523462610/en/Obsidian-Therapeutics-Announces-Positive-Clinical-Data-from-OBX-115-in-Patients-with-Advanced-Melanoma-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting
May 24, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next